The FDA is taking legal action against a compounding pharmacy after 17 hospital patients acquired infections from contaminated injectable drugs.
In August 2013, Specialty Compounding, LLC, issued a nationwide voluntary recall of all lots of its unexpired sterile products. The recall came after 17 cases of hospital-acquired infection were linked to injectable drug products supplied by the company. Patients were reported to have ...
continue reading...